Overall rank by patents
#4,557
of 49,997 tracked assignees
USPTO PatentsView assignee record - 77 granted patents across 17 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme).
The verdict
According to USPTO PatentsView, Emulate ranks #4,557 of 49,997 tracked US assignees by granted-patent volume, with 77 patents across 17 technology areas.
USPTO PatentsView assignee plate
Corpus R4557 · US Corporation #4,557 · 77 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Cardiovascular Systems, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Arrcus · near
46 score
Danfoss Power… · near
46 score
Emulate · this assignee
46 score
Nissin Kogyo · near
46 score
Silego Technology · near
46 score
3D Lighting… · lowest
7 score
What this shows Emulate's Innovation Score is 45.9/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Emulate, Inc. is a focused PatentsView assignee: 17 CPC subclasses with 79.2% of grants classified under C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme). Peak complete grant year is 2021 (17 grants) versus a trough of 1 in 2017. By volume, Emulate sits between Cardiovascular Systems, Inc. and Hangzhou Sanhua Research Institute Co., Ltd..
From 2019–2021 to 2022–2024, Emulate, Inc. moved from 34 to 34 grants (1.00x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cardiovascular Systems, Inc.
77 patents
Credo Technology Group Limited
77 patents
Dong-eui University Industry-academic Cooperation Foundation
77 patents
Dril-Quip, Inc.
77 patents
GAF Energy LLC
77 patents
GE Oil & Gas Pressure Control LP
77 patents
GLO AB
77 patents
Hangzhou Sanhua Research Institute Co., Ltd.
77 patents
Emulate, Inc.
77 patents
What this shows Emulate holds 77 patents at rank #4,557, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,557 in granted patent volume.
Other assignees with the most granted patents in Emulate's primary technology class.
Two PlainPatent-derived peer sets for Emulate, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (46 here).
Nearest assignees by average claims per patent (16.0 here).
Emulate's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 1.3% |
| 2018 | 3 | 3.9% |
| 2019 | 9 | 11.7% |
| 2020 | 8 | 10.4% |
| 2021 | 17 | 22.1% |
| 2022 | 10 | 13.0% |
| 2023 | 12 | 15.6% |
| 2024 | 12 | 15.6% |
| 2025partial year | 5 | 6.5% |
Top 15 of 17 technology areas
Overall rank by patents
#4,557
of 49,997 tracked assignees
45.9 out of 100
What to do with this data
Emulate, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.